LEPZACITINIB
UNII DQN3V3R84U

Substance Identification & Data

This profile provides standardized clinical and technical data for Lepzacitinib, uniquely identified by the FDA Unique Ingredient Identifier (UNII) DQN3V3R84U.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2321488-47-3 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

DQN3V3R84U

CAS Registry Number

2321488-47-3

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

LEPZACITINIB

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C18H21N5O3

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

QQOPOYMFJLUSBI-GFCCVEGCSA-N

Line notation for describing the chemical structure and connectivity of atoms.

NCI Thesaurus

C203081

National Cancer Institute reference terminology for clinical and research data.

PubChem CID

138624627

Unique identification number in the NCBI database of chemical substances.

INN ID

12644

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

LM-181

Identifier assigned by the United States Adopted Names Council.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

N(c1c2c(ncc1C(OCC)=O)[nH]cc2)[C@H]3CN(C(CC#N)=O)CCC3

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Lepzacitinib. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.